News
Discover essential antibody purification methods, from affinity chromatography to ion exchange chromatography, for research ...
Proof-of-concept studies ongoing in lupus nephritis (LN), systemic sclerosis (SSc) and antibody mediated rejection (AMR); topline results expected for LN in fourth quarter of 2025, SSc in second half ...
CDI Labs Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today announced the launch of its Pan-isotype Analysis Platform for serum antibody ...
It is well known that feeding newborn mammals sufficient volumes of good-quality colostrum in the first hours after birth ...
The joy in medicine is connecting with the patient,” Mary C. Tobin, MD, told Healio. “Deeply listening to people is healing.” ...
Hansa Biopharma AB: Hansa Biopharma announces key executive appointments to support continued growth
Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced three leadership appointments. Brian Gorman joins Hansa as Chief Legal Officer ...
Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...
9d
hoopLA Blog on MSNThe Growing Demand for Nanobody Discovery Services in Modern TherapeuticsAs therapeutic research moves toward more targeted, efficient, and scalable solutions, nanobodies—also known as VHH ...
Nipah virus research in Kerala focuses on transmission from bats to humans, utilizing novel pseudovirus neutralization test for study.
Fapon, a global leader in life sciences, will unveil its innovative one-stop IVD solutions at ADLM 2025, from July 29 to 31 in Chicago, IL. Fapon aims to be the trusted global partner for laboratories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results